|
|
Announcing the Reeve-Irvine Research Center’s 2nd Annual Clinical Lectureship featuring Dr. Michael G. Fehlings. Wed., Feb. 10th at 6pm in the William J. Gillespie Neuroscience Research Facility, free of charge. A special dinner with Dr. Fehlings follows the lecture, $150 per person space limited. Please indicate with RSVP your interest in the dinner. RSVP to Tania Cusack 949-824-5925 or tcusack@uci.edu
|
|
|
|
 |
| The mission of the Reeve-Irvine Research Center is to find new treatments for spinal cord injury through the collaborative research and educational efforts of prominent scientists and clinicians both at the University of California, Irvine and around the world. |
|
 |
| Approximately
1.9% of the U.S. population, or some 5,596,000 people, report some form
of paralysis, among whom, some 1,275,000 are paralyzed as the result of
a spinal-cord injury. ("One Degree of Separation | Paralysis and Spinal
Cord Injury in the United States" published by the Christopher &
Dana Reeve Foundation, 2009). |
|
 |
| There are a number of potential targets for therapy for SCI, and scientists at the RIRC address many of these. Importantly, some of the most promising strategies, and the ones that are closest to clinical application, involve interventions during the acute post-injury period (days to weeks after the injury). |
|
 |
The purpose of the Clinical Spine Initiative is to create an
unparalleled comprehensive spine center dedicated to providing a
continuum of clinical care from the moment of injury/paralysis
throughout life and providing the infrastructure for cutting-edge
translational spinal research. |
|
|